FindTrial
Sign In

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
EU CTR
Registry ID
EUCTR2013-002714-12-FR
Enrollment
Unknown
Registered
2015-12-09
Start date
2013-09-13
Completion date
Unknown
Last updated
2016-01-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Trade Name: CRESTOR Pharmaceutical Form: Coated tablet Other descriptive name: ROSUVASTATIN CALCIUM Concentration unit: mg milligram(s) Concentration type: equal Concentration number: 20- Pharmaceutic

Sponsors

CHU DE CLERMONT FERRAND
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range 40 F.1.3 Elderly (>=65 years) yes F.1.3.1 Number of subjects for this age range 40

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Main Objective: ;Secondary Objective: ;Primary end point(s):—

Countries

France

Contacts

Public ContactATTACHE DE RECHERCHE CLINIQUE

CHU DE CLERMONT FERRAND

ggouby@chu-clermontferrand.fr3304 73 754 962

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026